1.0CTGCThttps://ctgct.si/en/Rodrigo Ortizhttps://ctgct.si/en/author/rodrigoctgct/rich600338<blockquote class="wp-embedded-content" data-secret="u13c8LLuaW"><a href="https://ctgct.si/en/objave/next-generation-t-cell-therapies/">Next-Generation T-Cell Therapies: From Laboratory Engineering to In Vivo Programming</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://ctgct.si/en/objave/next-generation-t-cell-therapies/embed/#?secret=u13c8LLuaW" width="600" height="338" title="“Next-Generation T-Cell Therapies: From Laboratory Engineering to In Vivo Programming” — CTGCT" data-secret="u13c8LLuaW" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://ctgct.si/wp-includes/js/wp-embed.min.js /* ]]> */ </script> https://ctgct.si/wp-content/uploads/2026/05/Tom-Fox-1.png624349In our latest edition of the CTGCT Science Talks webinar series we had Dr. Thomas Fox, a clinician-scientist whose work bridges the gap between the clinical-laboratory interface working across Harvard Medical School and the University College London. His research focuses on "programmable" T-cell therapies, a field of medicine where we no longer rely solely on external chemicals or drugs to fight disease. Instead, scientists are learning how to rewrite the genetic code of our own immune cells to transform them into "living medicines" capable of seeking out and destroying cancer or correcting rare genetic disorders.